FIRST MANHATTAN CO. LLC. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$297
+3.5%
5000.0%0.00%
Q2 2023$287
-18.2%
5000.0%0.00%
Q1 2023$351
-68.9%
5000.0%0.00%
Q4 2022$1,130
+13.0%
5000.0%0.00%
Q3 2022$1,0000.0%5000.0%0.00%
Q2 2022$1,000
-50.0%
5000.0%0.00%
Q1 2022$2,000
-66.7%
5000.0%0.00%
Q4 2021$6,000
-25.0%
5000.0%0.00%
Q3 2021$8,0000.0%5000.0%0.00%
Q2 2021$8,000
-72.4%
500
-16.7%
0.00%
Q2 2018$29,000
-54.0%
6000.0%0.00%
Q1 2018$63,0006000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2018
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
Virtus ETF Advisers LLC 72,018$230,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders